Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06727071 · ClinicalTrials.gov registry record · NA

Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes

A NA study, sponsored by University of California, San Diego.

Not yet
Registry status
NA
Development phase
20
Enrollment target

NCT06727071 is a NA study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06727071, a NA study, has not yet begun recruiting, sponsored by University of California, San Diego.

NOT YET RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This is a single-site study using wearable sensor technology (CGM and smartwatch) to better explain low blood sugars in patients living with type 1 diabetes. Up to 20 participants with T1D will wear a continuous glucose monitor (CGM) and a smartwatch to collect information about hypoglycemia (low blood sugar), heart rate variability (HRV), and sleep for 4 weeks. The main goal is to create a hypoglycemia risk score using wearable sensor metrics that can be easily applied to all patients with T1D to identify those at greater risk of hypoglycemia.

Interventions

  • PROCEDURE Hyperglycemic clamp

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-02-01
Est. Completion 2026-06-30
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT06727071

The ClinicalTrials.gov registry entry for NCT06727071 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hyperglycemic clamp is the first listed.

NCT06727071 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06727071 about?

NCT06727071 is a clinical study titled "Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes". This is a single-site study using wearable sensor technology (CGM and smartwatch) to better explain low blood sugars in patients living with type 1 diabetes. Up to 20 participants with T1D will wear a continuous glucose monitor (CGM) and a smartwatch to collect information about hypoglycemia (low b...

What is the current status of trial NCT06727071?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-01. Estimated completion is 2026-06-30.

What interventions are being tested in trial NCT06727071?

The interventions under investigation include: Hyperglycemic clamp (PROCEDURE).

Who is sponsoring clinical trial NCT06727071?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.